ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

HAI Delivery Extends Survival In Patients With Liver Metastasis

March 31, 2006

Phase II Study Finds Dasatinib May Overcome ALL Resistance

May 25, 2007

Kimmel Foundation To Donate $1 million for Cancer Research

June 28, 1996

ACS Honors Cady, Rimer For Work In Cancer Control.

December 8, 2000

Four More COP Awards Announced

January 9, 1981

Three Institutions In Texas To Form Center For Childhood Cancer Epidemiology Research.

February 2, 2001